- Home
- SCNX vs NTIP Comparison
SCNX vs NTIP Comparison
Compare SCNX & NTIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCNX
- NTIP
- Stock Information
- Founded
- SCNX 2010
- NTIP 1990
- Country
- SCNX United States
- NTIP United States
- Employees
- SCNX N/A
- NTIP N/A
- Industry
- SCNX Other Pharmaceuticals
- NTIP Multi-Sector Companies
- Sector
- SCNX Health Care
- NTIP Miscellaneous
- Exchange
- SCNX Nasdaq
- NTIP Nasdaq
- Market Cap
- SCNX 14.4M
- NTIP 28.6M
- IPO Year
- SCNX 2020
- NTIP 1998
- Fundamental
- Price
- SCNX $0.98
- NTIP $1.20
- Analyst Decision
- SCNX
- NTIP
- Analyst Count
- SCNX 0
- NTIP 0
- Target Price
- SCNX N/A
- NTIP N/A
- AVG Volume (30 Days)
- SCNX 129.8K
- NTIP 7.6K
- Earning Date
- SCNX 08-10-2025
- NTIP 08-11-2025
- Dividend Yield
- SCNX N/A
- NTIP 8.00%
- EPS Growth
- SCNX N/A
- NTIP N/A
- EPS
- SCNX N/A
- NTIP N/A
- Revenue
- SCNX $146,901.00
- NTIP $250,000.00
- Revenue This Year
- SCNX N/A
- NTIP N/A
- Revenue Next Year
- SCNX N/A
- NTIP N/A
- P/E Ratio
- SCNX N/A
- NTIP N/A
- Revenue Growth
- SCNX N/A
- NTIP N/A
- 52 Week Low
- SCNX $0.69
- NTIP $1.16
- 52 Week High
- SCNX $23.77
- NTIP $1.78
- Technical
- Relative Strength Index (RSI)
- SCNX N/A
- NTIP 47.15
- Support Level
- SCNX N/A
- NTIP $1.20
- Resistance Level
- SCNX N/A
- NTIP $1.27
- Average True Range (ATR)
- SCNX 0.00
- NTIP 0.04
- MACD
- SCNX 0.00
- NTIP -0.00
- Stochastic Oscillator
- SCNX 0.00
- NTIP 30.00
About SCNX Scienture Holdings Inc. Common Stock
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.
About NTIP Network-1 Technologies Inc.
Network-1 Technologies Inc is involved in the business of the development, licensing, and protection of intellectual property assets. The company's current plan includes continuing to pursue licensing opportunities for its intellectual property assets.